Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study.

Introduction: Type 2 diabetes mellitus (T2D) has acquired epidemic proportions worldwide. In recent years, new oral glucose-lowering drugs (OGLD) have emerged that improve the cardiovascular-kidney-metabolic control in T2D people.

Objectives: To compare the baseline clinical-biological characteristics among T2D people to whom had added-on dapagliflozin (DAPA group) or another OGLD (SOC group) second-line hypoglycaemic therapies among the AGORA study population.

Social Disadvantages and Intergenerational Solidarity Views From Older Adults: A Qualitative Study.

In this article we aim at understanding the influence of social disadvantages on intergenerational solidarity. For this study, we have considered biographical research through narratives. These narratives help explain and reflect on the beliefs of the participants, implicit theories, and their life experiences.